Fresenius Medical Care Past Earnings Performance
Past criteria checks 4/6
Fresenius Medical Care's earnings have been declining at an average annual rate of -20.9%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 2.7% per year. Fresenius Medical Care's return on equity is 5.9%, and it has net margins of 3.4%.
Key information
-20.9%
Earnings growth rate
-20.4%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 2.7% |
| Return on equity | 5.9% |
| Net Margin | 3.4% |
| Next Earnings Update | 25 Feb 2025 |
Recent past performance updates
Recent updates
Fresenius Medical Care: Let's Look At The Upside
Oct 04Fresenius Medical Care: Significant Upside Remains
Jun 25Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns
Feb 23Fresenius Medical Care: Don't Let The Ozempic Kidney Failure Scare You Off
Oct 12Fresenius Medical Care: Other Stocks Still Better, But Upside Exists
Jun 01Fresenius Medical Care Q4 2022 Earnings Preview
Feb 21Fresenius: The Company Is Climbing, And I'm At 'Buy'
Jan 06Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)
Oct 27Fresenius Medical gains after report of activist Elliott stake in Fresenius SE
Oct 19Fresenius cut to Hold at Jefferies citing staffing issues and inflation
Oct 10Fresenius gets award to provide dialysis services to U.S. military veterans
Aug 30Fresenius appoints head of pharma unit as new CEO
Aug 19Fresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend Aristocrat
Jul 30Fresenius Medical Care accused of Medicare fraud in dialysis
Jul 13Fresenius: The Upside Is Getting Bigger
May 02You Really Want To Know About Fresenius Medical Care
Aug 28Fresenius Medical drops 12% on disappointing 2021 outlook
Feb 02Fresenius Medical Care EPS beats by €0.06, misses on revenue
Oct 29Revenue & Expenses Breakdown
How Fresenius Medical Care makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 19,239 | 659 | 3,148 | 199 |
| 30 Jun 24 | 19,415 | 530 | 3,186 | 212 |
| 31 Mar 24 | 19,474 | 484 | 3,190 | 224 |
| 31 Dec 23 | 19,454 | 499 | 3,196 | 232 |
| 30 Sep 23 | 19,463 | 450 | 3,156 | 228 |
| 30 Jun 23 | 19,622 | 596 | 3,180 | 236 |
| 31 Mar 23 | 19,554 | 602 | 3,163 | 235 |
| 31 Dec 22 | 19,398 | 673 | 3,170 | 229 |
| 30 Sep 22 | 19,048 | 763 | 3,104 | 234 |
| 30 Jun 22 | 18,393 | 806 | 3,018 | 225 |
| 31 Mar 22 | 17,957 | 878 | 3,091 | 222 |
| 31 Dec 21 | 17,619 | 969 | 2,773 | 221 |
| 30 Sep 21 | 17,372 | 918 | 3,011 | 205 |
| 30 Jun 21 | 17,344 | 998 | 2,986 | 198 |
| 31 Mar 21 | 17,581 | 1,131 | 2,868 | 197 |
| 31 Dec 20 | 17,859 | 1,164 | 2,966 | 194 |
| 30 Sep 20 | 18,039 | 1,330 | 2,991 | 190 |
| 30 Jun 20 | 18,044 | 1,309 | 3,016 | 187 |
| 31 Mar 20 | 17,832 | 1,212 | 3,099 | 185 |
| 31 Dec 19 | 17,477 | 1,200 | 2,944 | 168 |
| 30 Sep 19 | 17,196 | 1,282 | 2,967 | 138 |
| 30 Jun 19 | 16,835 | 1,234 | 2,978 | 122 |
| 31 Mar 19 | 16,704 | 1,974 | 2,898 | 111 |
| 31 Dec 18 | 16,547 | 1,982 | 2,857 | 114 |
| 30 Sep 18 | 16,676 | 1,951 | 3,126 | 131 |
| 30 Jun 18 | 16,954 | 1,975 | 3,185 | 133 |
| 31 Mar 18 | 17,211 | 1,250 | 3,374 | 130 |
| 31 Dec 17 | 17,784 | 1,280 | 3,640 | 111 |
| 30 Sep 17 | 17,771 | 1,249 | 3,417 | 134 |
| 30 Jun 17 | 17,647 | 1,244 | 3,407 | 145 |
| 31 Mar 17 | 17,201 | 1,239 | 3,262 | 144 |
| 31 Dec 16 | 16,570 | 1,144 | 3,133 | 147 |
| 30 Sep 16 | 16,101 | 1,063 | 3,047 | 143 |
| 30 Jun 16 | 15,841 | 998 | 3,027 | 136 |
| 31 Mar 16 | 15,402 | 933 | 2,961 | 130 |
| 31 Dec 15 | 15,455 | 955 | 2,895 | 128 |
| 30 Sep 15 | 15,345 | 939 | 2,919 | 118 |
| 30 Jun 15 | 15,246 | 948 | 2,839 | 114 |
| 31 Mar 15 | 15,428 | 977 | 2,816 | 115 |
| 31 Dec 14 | 13,329 | 864 | 2,434 | 101 |
| 30 Sep 14 | 12,413 | 839 | 2,242 | 97 |
| 30 Jun 14 | 11,112 | 775 | 1,999 | 91 |
| 31 Mar 14 | 10,882 | 791 | 1,962 | 91 |
| 31 Dec 13 | 10,816 | 806 | 1,937 | 91 |
Quality Earnings: FMS has high quality earnings.
Growing Profit Margin: FMS's current net profit margins (3.4%) are higher than last year (2.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FMS's earnings have declined by 20.9% per year over the past 5 years.
Accelerating Growth: FMS's earnings growth over the past year (46.5%) exceeds its 5-year average (-20.9% per year).
Earnings vs Industry: FMS earnings growth over the past year (46.5%) exceeded the Healthcare industry 10.4%.
Return on Equity
High ROE: FMS's Return on Equity (5.9%) is considered low.